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SUMMARY 
The purpose of this study was to d evelop and 
characterize a panel of monoclonal ·antibodies specific 
for epitopes on the Nebraska strain of bovine 
coronavirus (BCV) . The hybridomas were prepared by 
fusion of spleen cells from BALB/c mice hyperimmunized 
with BCV and from SP2/0M l ,  NS -1 , and P3-X63-Ag8 .65 3 
myeloma cell lines. Seven hybridoma clones were 
derived from the fusions. The immunoglobulin isotype 
IgGl was the most common antibody prod uced by the 
hybridomas. BALB/c mice were inoculated with hybridorna 
cells to produce ascitic fluids. Assays were performed 
on the ascitic fluids to determine which biological 
functibns of the bovine coronavirus virions were 
identified by each of the seven monoclonal antibod ies. 
One of the seven monoclonal antibodies (2 5 -48 ) 
neutralized BCV, one (4-7) inhibited hemagglutination, 
while the remai�ing five reacted on indirect 
immunofluorescence and enzyme-linked immunosorbent 
assays. 
All monoclonal antibodies reacted with BCV on 
the indirect immunofluorescence assay and titers ranged 
from 1:10 to 1:32 0 0 .  Three (71-44, 6-1, and 6-4) of 
ix 
the seven monoc lona l ant ibodi e s  a l so reacted on 
indi rect immuno f luore scence a s s ay s wi th 
hemagg lutinating encepha lomy e l i t i s vi ru s  ( HEV) o f  
swine, wh i ch i s  ant i gen i ca l ly re l ated to BCV . The se 
three monoc lona l antibod i e s  are d i rected aga inst an 
epi tope common to both BCV and HEV . 
Hyb ridoma 4 - 7  produced monoc lona l antibody that 
inh ib ited hemagg lutinati on of rat eryth rocyte s by BCV , 
and the re fore , recogni z e d  epi tope s common to the v i ra l  
hemagg luti nin . C lone 2 5 - 4 8  produced monoc lona l 
antibody wh i ch neutra l i z e d  BCV at t i te r s  ranging from 
1 : 3 2 to 1 : 1 0 2 4 . The ob s ervat i on that Mab s wh ich 
prevented hemagg lut ina t i on i ndependent o f  
neutra l i z ation sugge s te d  tha t e i ther the se funct i on s  
we re on separate g lycoprote i n s  o f  the vi rion o r  the 
hemagg lut i n i n  and neutra l i z a t i on epi tope s are separate 
reg ion s  on the same g lycoprote in . The latter 
hypothe s i s  wa s sugge s ted by the immune ele ctron 
mi cro s copy re su l t s . When BCV wa s treated wi th 
brome lain , mo st  o f  the outer row o f  surface proj e ct i on s 
we re removed and the ant i gen ( BCV ) -ant i body ( 2 5 - 4 8 ) 
reaction ob se rved on immune e lectron mi croscopy wa s 
enhanced . S ince b rome l a i n  ha s been reported to remove 
a l l  g lycoprote ins except the hemagg lut i n i n  (33) , 
X 
the enhanced rea c t i on between Mab 2 5�4 8 and BCV on 
immune e lectron mi cro s copy sugge s t s  that the 
neutra l i z ing Mab 2 5 - 4 8 reacted with the vira l 
hemagg lut i n in . Furthe r characteri zat i on o f  the 
monoc l ona l ant ibod i e s  obta ined in  thi s · study by Wes te rn 
b lotting or  immunopre c ip i t i on wi l l  be requi red to 
c lea r ly de f ine the mo l e cu l a r  we ights  of the prote i n s  to 
whi ch the monoc lona l ant i bodi e s  react . 
In summa ry , a l l  o f  the monoc lona l ant ibod i e s , 
7/7 , had immuno f luore scent t i te r s  ( !FA ) aga i n s t  BCV , 
but 3/7 ( 7 1- 4 4 , 6 - 1 , and 6 - 4 ) a l so reac ted wi th HEV 
whi ch ind i ca te s  that the se ant i gen i ca l ly re late d 
v i ruse s  sha re a common v i ra l p rote in . One monoc lona l 
ant ibody ( 2 5 - 4 8 )  re cogn i z ed a neutra l i z a t ion epi tope , 
and one (4 - 7 ) recogn i z ed the v i r i on hemagg luti n i n , 
sugge sting the se are sepa rate e p i tope s on di f ferent 
g lycoprotein s or are ep i tope s on the s ame g lycoprote in 
pre sent o n th e viri on sur face . The latter hypoth e s i s  
wa s favored by the immune e lectron mi cro scopy 
ob serva t i ons , whi c h  revea l t h a t  the neutra l i z a i ng 
ant ibody bi nd s to the hemagg luti n i n  o f  brome l a in 
treated BCV . 
x i  
INTRODUCTI ON 
Bovine coronavi rus ( BCV) i s  an acute ente r i c  
di sea se o f  catt le , mo s t  o f ten f�ta l · in newborn c a lve s 
( 4 6 , 7 1, 72 ) and wide ly preva l e nt s ince mo st adu lt  c at t le 
h ave antibody to th i s  v i ru s  ( 5 4 ) . The ab sorptive 
epi the l i a l ce l l s  cove r ing the sma l l  inte stina l vi l l i 
and the crypt ce l l s o f  the co l on a re the mai n  targets  
o f  th e  v i ru s  ( 4 1 , 46 , 7 1 ) . The in fection o f  the se ce l l s 
leads to vi l lou s atrophy , re su lting in a ma labsorptive 
di arrhea , dehydra tion , and o ften dea th ( 4 1 , 4 6 ) . 
Af fected herd s o f  catt l e  wi th 1 0 0  percent morbidi ty and 
up to 50 percen t  morta l i ty in susceptib l e  ca lve s a re 
not uncommon ( 4 ) . 
Bovine co ronav i ru s  be l ong s to the Coronav i ri dae 
fami ly , a group of enve loped v i ru s e s  po s se s sing a 
s ing l e  stranded l inear RNA genome o f  po s i tive po l a r i ty 
( 2 0 , 7 1 ) . The bovine coronavi ruse s have a.doub le row o f  
surface pro j ection s  o r  enve lope pep lome r s , wh i le other 
members o f  th i s  fami l y  po s se s s  on ly a s ing le row o f  
pep lomers ( 7 1 ) . The se pep lo�e r s  are g lycoprote in s 
pre sent on the sur face o f  the v i ru s  and funct i on a s  
anti recepto rs ( 1 6 , 2 0 , 2 7 , 3 6 ) , hemagg lut inins ( 1 3 , 3 2 ) , 
s i te o f  neutra l i z at i on ( 1 3 , 1 4 ) , and fu s i on prote ins 
( 1 4 ) . Four g lycoprote i n  ( gp )  pep lomers , 1 4 0 , 1 2 0 , 1 0 0 , 
and 2 6K , have b een i denti fi ed on the sur face of BCV 
( 3 2 ) . The 1 2 0 - 1 4 0 K  gp ha s been ident i f ied a s  the v i ra l 
hemagg lut inin by one group o f  i nve stiga tors ( 3 2 , 3 3 ) ,  
whereas  a second group i denti f i e s  a lOSK gp a s  the 
hemagg lutinin ( 6 8 ) . The fun c t i on s  o f  the other th ree 
sur face gp of BCV have not been de l i neated . With i n  the 
mamma l i an coronavi ru s e s , BCV i s  anti geni ca l ly re l a ted 
t o  mou se hepa t i ti s v i ru s  ( MHV) , hemagg lutinating 
encepha lomye l i t i s  vi ru s  ( HEV) , and the human 
re spi ratory v i ru s  ( OC- 4 3 )  ( 7 1 ) . 
The prec i se function o f  v i rion protei n s, such 
as the four sur face g ly cop rote i n s  of BCV , can be st  be 
determined by u s ing monoc l ona l antibodi e s  ( Mab s ) . · 
The se Mab s  are speci f i c  for  epi tope s of  
d i f fe rent v i ri on prote i n s and c an be used to  de termine 
the function o f  such prote i n s . The production o f  Mab s 
to coronaviru s e s  ha s a l lowed the determination o f  
function for sur face g p  o f  MHV ( 7 0 ) , i n fectiou s  
b ronch i t i s v i ru s  (IBV ) ( 1 3 ) , and tran smi s s i b le 
ga stroente r i t i s v i ru s  ( TGE ) ( 16 ) . Two report s have 
de sc ribed the deve lopment o f  Mab whi ch neutra l i z e  and 
prevent hemagg lutination o f  BCV ( 17 , 6 8 ) . Some of the se 
Mab s to BCV neutra l i z ed the v i ru s , some preven ted 
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hemagglutination, and others had both functions 
{ 1 7 , 6 8 ) . Results of immunoprecipitation tests 
suggested that these Mabs precipitated either a gp 
12 0 -14 0 { 1 7 ) , or a gp 10 5 { 6 8 ) . These results have 
been confusing since King et. al. 
the gp 14 0 as the hemagglutinin. 
{ 3 3 ) . have identified 
The gp 14 0 is 
analogous to the gp 120 described by Deregt et. al. 
{ 1 7 ) , but the gp 10 5 is a gp on the outer row of 
projections (6 8 ) . Thus the gp 12 0 -14 0 or gp 10 5 may be 
the site of both neutralization and hemagglutination , 
or the sites may be separate since some Mabs neutralize 
but do not hemagglutinate- ( 1 7,6 8 ) . Presently , the site 
of the BCV hemagglutinin and neutralization have not 
been definitely identified. 
The purpose of the present study was to develop 
and characterize a panel of Mabs to the Nebraska strain 
of BCV . The aim of the study was to obtain information 
on the function of the virion proteins with the hope 
that these Mabs could eventually be used to improve 
diagnosis and detection of the BCV . The general 
biological properties of seven hybridomas, two directed 
against surface gp and five against internal viral 
proteins , are discussed. 
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LITERATURE REVIEW 
The fami ly Coronavi r i da e  are c la s s i fied on the 
ba s i s  of s imi l a r  morpho l og i c a l , bi ochemi ca l , and 
bi ophy s i c a l properti e s  ( 5 8 , 5 9,60 ) . Coronavi ru s e s  are 
p l eomorph i c  part i c l e s  60 to 200 nm in diameter 
( 5 9 , 60 , 7 1 )  1 and po s se s s  a l inear genome o f  
s ing le- stranded RNA wh i ch i s  po s i tive- stranded , 
i n fe ctious , po lyadeny l a ted ( 2 11 5 8 , 7 1 ) , and ha s a 
mo lecu lar we ight o f  5 - 7  x 10
6 
( 5 8 ) . Coronav i r i dae a re 
the on ly recogn i z ed v i ru s e s wi th a s i ng le- stranded , 
po s i t ive po lari ty , RNA genome wi th nuc leocap s i d s  o f  
he l ica l symme try surrounded b y  a l i pid enve lope ( 2 1 ) . 
The l ip i d  enve lope i s  obta ined a s  nuc leocapsids bud 
into the lumen of the rough endop la smi c reti cu lum 
( 2 1 , 2 7 , 5 81 7 1 )  1 or Go lgi apparatu s  ( 2 7 ) . The l ip i d  
enve lope i s  b i ochemi ca l ly a n d  st ructura l ly identi c a l to 
the ho st  ce l l  membrane s f rom wh i ch it i s  der ived 
( 5 1 ) . Chemi ca l ly , the enve l ope conta ins neutra l 
lipids , pho spho l ip i d s , and g lyco l ipids ( 2 1 )  and 
con s i st s  structura l ly of a l ip i d  b i layer ( 2 1,7 1) .  
Prior to budding o f  the nuc l eoca p s i d s , vira l prote i n s  
a r e  inse rted into t h e  memb rane s o f  the rough 
endop l a smi c reti cu lum and the Go lgi apparatus  ( 6 0 ) . 
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Enve loped vira l part i c le s ,  migrate through the Go lgi 
apparatus and are packaged into secretory ve s i c l e s . 
The se ve s i c l e s  fuse wi th the p la sma membrane and the 
viri on s  egre s s  from intact c e l l s , but do not bud from 
the p la sma membrane ( 2 7 ) . Thu s , coronav i ruse s may be  
re lea sed from ce l l s by u t i l i z i ng a ce l lu l ar tran sport 
mechani sm deve loped for s e c re t i on or  exocyto s i s  of  the 
contents  o f  secre tory ve s i c l e s  ( 6 3 , 6 4 ) . Enve loped , 
extrace l lu lar vi r i on s  h ave a fr inge o f  c lub- shaped 
sur face projection s  o r  pep l ome r s , wh i c h  are 2 0  nm in 
length and surround the v i ru s  part i c le ( 5 9 , 7 1 ) . The se 
pep lome r s  give the characteri s t i c  morpho logy of a 
" so lar corona " or " crown " from wh i ch the fami ly name i s  
derived ( 6 3 ) . 
Coronavi ru se s  h ave three ma j or c la s se s  o f  v i ru s  
prote ins, the sur face projecti on ( pep lomer ) prote i n, 
nuc l eocap s i d  prote in, and the tran smembrane ( matr i x )  
prote in� The pep lomer prot e i n  i s  a g lycosy lated 
po lypeptide ( gp )  of 8 0 , 0 0 0  to 2 0 0 , 0 0 0  mo lecu lar we ight 
( 5 8 , 6 0 ) . The pep lome r prote in function s  a s  the vi ra l  
atta chment prote in or ant i receptor, wh i c h  b inds to the 
receptor on the p l a sma memb rane o f  the host ce l l  
( 2 0 ) . I t  a l so function s  i n  ce l l  fu s ion, and, in some 
stra in o f  vi ru s, i s  the hemagg lutinin ( 1 4 , 5 8 ) . 
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Monoc lona l antibodi e s  prep a re d  aga i nst the pep lome r 
prote i n s  neutra l i z e  vi ra l i n fectivi ty suggest ing t h a t  
t h e  pep lomer prote i n s  a re t h e  s i te o f  v i ra l 
neutra l i z ation . The pep lomer pro te ins may be remove d  
b y  treatment wi th prote a se s such a s  brome lain o r  b y  
growing t h e  v i ru s  in ce l l  cu l ture s wi th med i a  
contai ning tun i camy c i n , a n  ant ib io t i c  wh i ch inhib i t s  
g ly cosy lation ( 3 2 , 5 8 ) . U s e  o f  e i ther protea se s o r  
tun i camycin re su l t s  i n  vi rions  lacking pep lome r s  and 
the se v i ru s e s  do not b ind receptors on the ce l l  sur face 
or i n i t iate infection ( 2 7 ) . 
The nuc leocap s i d  protein i s  a nong lycosy l ated 
prote in of 5 0 , 0 0 0  to 6 0 , 0 0 0  mo lecu lar wei gh t  ( 6 0 ) . 
Thi s  protein i s  surrounded by the l ipid enve lope , whi ch 
protects  the nuc leocap s i d  f rom prote a s e s  such a s  
b rome lain ( 3 2 , 6 3 ) . Th i s  prote i n  interact s  with ne� ly 
formed vi ra l RNA to form the r ibonuc leoprote in o f  the 
vira l nuc leocap s i d  ( 6 4 ) . Pho sphory l ati on of 
nuc leocap s i d  prote i n s  ha s b e en demon strated for bovine 
coronavi rus  ( BCV) ( 3 2 , 5 8 ) , i n fec t i ou s  b ronchi ti s v i ru s  
· ( IBV) ( 3 7 , 5 8 ) , and MHV ( 5 8 , 62 ) . The funct ion o f  
nuce locap sid protein pho sphory l a t i on i s  unc lear , 
a lthough inte raction between nuc leocap s i d  
r ibonuc leoprote in a n d  t h e  v i ra l matrix prote in may b e  
6 
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f�c i li tated by pho sphory l a t i on o f  prote i n s  du ring vi ru s  
a s semb ly ( 6 0 ) . It h a s  a l so b e en reported, in · studie s 
u si ng a mou se ·coronavi ru s, that the degree o f  
nuc leocap s i d  protein pho sphory lat i on· regu late s the 
interaction o f  the c ap s i d  prote i n s  with· the vira l RNA . 
Th i s  inte raction wou l d  then i n f luence o r  regu l a te the 
formation of vi ra l nuc leoc ap s i d s  ( 6 2 ) . 
The tran smemb rane ( matrix ) protein i s  a 
g lyco sy lated po lypep t i de ( gp )  o f  2 0, 0 0 0  to 3 5, 0 0 0  
mo lecu lar weight ( 5 8, 6 0 ) . The g lycosy l a ted region o f  
th i s  protein i s  exte r ior t o  the vi r i on enve l ope 
(5 9 )  , whi le the rema inde r of the prote in i s  parti a l ly 
concea led within the v i ra l  enve lope and on the inner 
surface of the enve lope ( 6 4 ) . When treated with 
prote a s e s, such as b rome la in , the ma trix prote in i s  
s l igh t ly reduced s ince the porti on o f  the gp exte rior 
to the vi rion enve lope is  removed a fter treatment 
( 2 0 , 6 3 ) �  The prote a s e  re s i stant porti on of  the 
tran smemb rane protein i s  located on the interna l s ide 
of the vira l enve lope ( 6 3 ) . Monoc lona l antib6d i e s 
di rected aga inst the ma t r i x  prote in o f  MHV do not 
neutra l i z e  the vi ru s  (14 ). The lack o f  neutra l i z a tion 
by monoc lona l ant ibody to the matrix gp sugge s t s  that 
the epi tope for neutra l i z a t i on of co ronavi rus  is not 
located on the ma trix prote i n  and th i s  wou ld be 
expected s ince thi s prote i n  i s  not as e a s i ly acce s s i b l e  
t o  antibody a s  a re t h e  surface projections . The matrix 
prote in of  MHV and other coronavi ruses is  re spon s i b l e  
for determin ing con forma t i on o f  t h e  vi rion and 
de s i gnating the s i te o f  nuc leocap s i d  budding ( 2 7 ) . 
Coronav i ru se s we re i n i t i a l ly grouped a s  a 
separate vi rus  fami ly on the b a s i s o f  the i r  di stinct 
e lectron mi cro scopic appea ranc e . Al though data on the 
antigeni c  interre lation sh ip s  among the Coronavi r i da e  
a r e  not y e t  comp lete , t h e  v i ru s e s  have been tentati ve ly 
p l aced i nto four antigeni c  c lu s t e r s  ( Tab le 1 ) . The s e  
antigeni c  c lusters cons i st o f  di stinct and unre l ated 
group s o f  avi an and mamma l i an coronaviruse s (71).· 
Group 1 coronav i ruse s inc lude the human coronavi ru s  
2 2 9 E ( HCV- 2 2 9 E ) , tran smi s s ib le ga stroenteri t i s vi ru s  
( TGE )  o f  swine , c anine c o ronav i ru s  ( CCV) , and fe l i ne 
infectious  pe r i ton i t i s v i ru s  ( FIPV) . The group 1 
coronavi ru s e s  a re c lo s e ly re l ated ant igenica l ly and 
share common anti geni c  de terminant s on the 
nuc leocap s i d , and enve l ope g lycoprote ins ( 3 0 , 3 9 , 5 0 ) . 
Coronaviruses  in group 2 are  ant igen i ca l ly unre l ated to 
group 1 and inc lude the human co ronavirus OC- 4 3  
( HCV-OC 4 3 ) , severa l se ro type s o f  MHV , BCV , and 
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TABLE 1 .  Ant i gen i c  cro s s - reactions  between 
coronavi ruse s 
Mamma l i an 
Group 1 
Human coronaviru s - 2 2 9 E 
Tran smi s s ib le gastroen te r i t i s 
Canine coronavi rus 
Fe l ine i n fectious pe r i ton i t i s 
Avi an 
Group 3 
Infectiou s  bronch i t i s  v i ru s  
Taken from Wege ( 7 1 ) . 
Group 2 
Human co ronavi rus-OC 4 3  
Mouse hepati ti s 
Bovine coronavi r u s  
Hemagg lutinat ing 
encepha lomye l i t i s 
Group 4 
Turkey coronavi rus 
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hemagg lutinat ing enc eph a l omye l i t i s virus ( HEV) o f  swine 
( 7 1 ) . Bov ine coronav i r u s  and HCV-OC 4 3  are c lo s e ly 
re lated ant igehi ca l ly w i th in thi s  group , but a l l  
members share common anti gen i c  determinants  ( 6 , 2 2 , 2 6 ) . 
Groups 3 and 4 a re the avian coronavi ruse s , avi an 
infectious  bronchi t i s vi ru s  ( IBV ) ( 3 9 , 7 1 ) , and turkey 
coronaviru s  ( TCV) , re spec tive ly ( 7 1 ) . The se avi an 
viru s e s  do not share ant i geni c  dete rminants wi th the 
mamma l i an coronav i ru s e s  o r  each other . 
Bovine coronavi ru s wa s ini ti a l ly i dent i f i ed i n  
fec a l s amp le s  o f  c a lve s wi th neonata l ca l f  d i a rrhea 
( 4 0 , 4 1 ) . Neonata l ca l f  d i arrhea caused by BCV produce s 
9 0 - 1 0 0 % morb i d i ty and a mort a l i ty a s  h igh a s  5 0 %  
depending on con d i t i on s  i n  the h e rd ( 4 ) . Neonata l c a l f  
d i arrhea i s  a prob lem o f  conce rn to produce r s  o f  bee f 
ca lve s s ince late winte r , e a r ly spring ca lving 
schedu l e s  expo s e  neonata l c a lve s to stre s sors 
( inc l ement weather ) ,  wh i ch incre a s e s  su sceptib i l i ty o f  
ca lve s to BCV ( 6 1) .  The inc i dence o f  BCV in bee f and 
dai ry ca lve s ha s not been adequa te ly a s se s sed , but i n  
one study i n  wh i ch feca l o r  i lea l content s o f  7 6 1  
ca lve s were examined by e le ctron mic ros copy for BCV , 
BCV wa s pre sent i n  1 7 %  o f  the samp le s  examined (47). 
Mo s t  o f  the ca lve s dete rmined to be shedding BCV in 
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the i r  fece s had d i a rrhea and some d ied from dehydrat i on 
( 4 7 ) . 
Mo st ca lve s a re i n fected wi th BCV at one day to 
4 wee k s  o f  age ( 4 , 4 7 , 4 9 ) . Gnotobiotic  and 
co l o s t rum-deprived ca lve s deve lop d iarrhea within 
n ineteen to th i rty h ou r s  a fter experimenta l inocu l a t i on 
wi th BCV ( 4 1 , 7 1 ) . D i arrhea pe r s i st s  for three to f ive 
day s and may re su l t  in severe dehydration and death or  
a pe rmanent reta rda t ion of  growth i n  ca lve s , wh i ch 
surv ive the in fec tion ( 4 6 , 7 1 , 7 2 ) . The vi l lous  
ep ithe l i a l  ce l l s o f  the  sma l l  inte st ine are the  target 
ce l l s for BCV . Vi ru s  rep l icat i on occur s in  the �i l lous 
absorptive ce l l s  of the jejunum , the i leum , the co l on , 
and the co lon i c  c rypt ce l l s  ( 4 1 , 4 6 , 7 1 ) . Vi rus 
rep l i cation in the jejunum and i leum re su lts  in  
de struction o f  vi l lou s epi the l i a l ce l l s , re su l ting in  
vi l lou s atrophy , which dec rea s e s the  absorptive sur face 
of  the sma l l  inte stine , produc ing a ma l ab sorpt�ve 
d i arrhea ( 4 1 , 4 6 ) . The le s i on s  i n  the co lon are 
var i ab le in seve rity and con fined to the co lon ic  c rypt 
ce l l s ( 4 6 ) . Bovine coronav i rus cause s more seve re and 
per s i stent le s ion s  in the sma l l  inte s tine than tho s e  
ob served in ca lve s inocu l a te d  w i th bovine rotav i ru s , 
wh i ch a l so produce s d i a rrhea in  ca lve s ( 4 1 , 4 6 ) . 
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Characteri z at i on o f  BCV depend s on the ab i l i ty 
to adapt the vi ru s  to rep l icate i n  ce l l  cu l ture . The 
addi ti on of proteo lytic en z yme s such as tryp s in to 
cu l ture med i a  s igni f i cant ly enh ance s ·viru s growth i n  
vi tro ( 1 5 ) . Th i s  re su l t  sugge s t s  that proteo lyt i c  
en zyme s in the inte s tina l tract may a l so promote o r  
enhance the in fect iv i ty o f  BCV , but thi s hypothe s i s  h a s  
n o t  been adequa te ly s tud i ed ( 7 1 ) . Bovine coronav i ru s  
c an b e  propagated o n  a cont inuou s ce l l  l ine of human 
recta l tumor ( HRT - 1 8  ce l l s )  , de rived from an 
adenocarc inoma ( 3 5 ) . E le c t ron mi cro s cop ic stud i e s  o f  
ce l l  cu lture propagated BCV reve a l that thi s  vi rus 
po s se s se s  an add i t i ona l laye r of  surface projection s  
not ob served o n  other co ronav i ru s e s  ( 7 , 6 1 ) . 
Bovine coronavi ru s  ha s f ive major s tructura l 
prote i n s . Four o f  the se prote i n s  are g lyco sy lated , 
partia l ly extera l to the v i r i on enve lope , and have 
mo lecu lar we igh t s  of 1 2 0 - 1 4 0 , 1 2 0 , 1 0 0 , and 2 6  kd ( 3 2 ) . 
The f i fth prote in i s  the nuc l eocap s id prote i n , wh i ch i s  
pho sphory lated , located inte rna l ly ,  and has a mo l e cu l a r  
we ight o f  5 2  kd ( 3 2 ) . T h e  1 2 0 - 1 4 0  gp exi s t s  a s  a 
d i su l fide - l i nked dime r o f  two g lycoprote in s of 6 5  kd 
and funct ions  a s  the v i r i on hemagg lutinin ( 6 , 3 2 , 3 3 ) . 
Treatment o f  BCV wi th b rome lain or pron a s e  
results in digestion-resistant 35 and 2 2  kd fragments 
that are located internally to the envelope of the 
virion (3 3 ) . The 35 and 2 2  kd fragments represent 
portions of the surface projections and transmembrane 
glycoproteins. 
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Hemagglutinating encephalomyelitis virus. In 
195 7 ,  a disease of nursing pigs characterized by high 
morbidity , vomiting , anorexia , constipation , and severe 
progressive emaciation was observed in Canadian swine 
herds (5 5 ) .  In the acute disease , vomiting and severe 
depression were the only clinical signs noted before 
death. The acute disease frequently progressed until 
affected suckling pigs became emaciated and died of 
starvation after a few weeks. Growth of surviving pigs 
was also premanently retarded. The condition was -
termed "vomiting and wasting disease" (5 5 ) .  Viral 
encephalomyelitis also appeared concurrently with the 
vomiting and wasting syndrome. The encephalomyelitis 
syndrome often progressed to produce muscle tremors ,  
blindness , and paddling in the later stages of the 
disease prior to death ( 1 , 4 3 ) -. Viral encephalomyelitis 
was most common and severe in pigs under two weeks of 
age (1), but affected pigs up to four weeks of age 
(5 1 ) . A hemagglutinating virus was isolated from 
438836 
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clinical specimens of pigs with vomiting and wasting 
disease and viral encephalomyelitis (23 ) .  Mengeling 
and Cutlip ( 4 3 )  were able to reproduce the central 
nervous system signs , and the vomiting and wasting 
syndrome using the same field isolates. The prototype 
field isolate designated as the 6 7N strain of HEV was 
isolated from the nasal cavity of an apparently healthy 
pig (4 3 ) . Greig et. al. ( 2 3 ) also isolated a virus 
from brain tissue of pigs with encephalomyelitis and 
could experimentally reproduce the "vomiting and 
wasting" syndrome as well as encephalomyelitis in 
suckling pigs. The 6 7N strain of virus and the virus 
isolated and described by Greig et. al. (2 3 )  were 
determined to be identical, and the name hemagglut­
inating encephalomyelitis virus ( HEV ) was proposed, 
because the virus hemagglutinated red blood cells and 
caused encephalomyelitis in susceptible pigs. Pigs 
experimentally inoculated with HEV develop anorexia and 
vomition after a four to six day incubation period ( 3 ) .
· 
The virus is apparently naturally transmitted through 
nasal secretions and the nasal passages are the primary 
site of replication. The virus multiplies in the 
epithelial cells of the nasal mucosa, tonsils, lungs, 
and small intestine (3). Following local 
rep l i cation in and near the nasa l passages , the vi ru s  
spreads v ia  the periphera l ne rvous system t o  the 
centra l nervous system and b ra i n  (2,3). 
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Hemagg lutinating encepha lo"myeli t is v i rus is 
antigenica l ly s imi l a r  to BCV and a lso contains five 
s t ructura l proteins . Four o f  the se proteins are 
g lycosy lated , parti a l ly exte rna l to the vi rion enve l ope 
and have mo lecu l a r  we ight s  o f  1 4 0 - 1 8 0 , 1 2 0 , 1 0 0 , and 
2 6 . 5  kd ( 8 , 5 2 ) . The fi fth protein is the nuc leocaps i d  
prote in , wh ich i s  phosphory l a ted , located inte rna l ly ,  
and has a mo lecu lar weight o f  5 6  kd ( 5 2 ) . The gp 
1 4 0 - 1 8 0  exist s a s  a disu l fi de - l inked dime r o f  two 
g ly coprote ins o f  7 6  kd and fun c t i ons as the virion 
hemagg lutinin ( 8 ) . Thus , the hemagg lutinin pre sent on 
the HEV is very s imi lar to the 1 2 0 - 1 4 0  kd g lycoprot e i n  
h emagg lutinin o f  BCV (33). 
Transmissib le ga s t roente r i t i s ( TGE ) wa s f i rst 
i dent i f i ed by Dby le and Hutch ing ( 1 8 )  and the 
e t i o logi ca l agent wa s later determined to be a 
coronavi rus (3 9 ) . Transmiss i b l e  gastroente ritis i s  a 
h i gh ly contagious , ente r i c  d i sease o f  swine 
characte r i z ed by a short incub a t i on pe riod ( 1 6 - 2 4  hrs ) , 
vomi ting , seve re diarrhe a , and h i gh morta l i ty in  
pig l e t s  under two weeks  of  age ( 9 , 2 4 , 2 5 , 2 8 ) . Mortality 
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in pig lets  unde r two wee k s  o f  age i s  usua l ly 1 0 0  
percent ( 2 4 , 2 5 ) . Like BCV , TGE rep l i c ate s in and 
de stroy s the vi l lous ep i th e l i a l  ce l l s in the sma l l  
inte s tine produc ing mar ked v i l l ou s  atrophy in the l owe r 
duodenum , j e j unum , and i l eum o f  p i g s. Thi s  re su l ts in 
an acute ma lab sorpt ive d i a rrhea ( 28 , 2 9 , 4 5 , 4 8 )  fo l lowed 
by dehydration and death ( 2 8 ) . 
Transmi s s ib le  ga s t roente r i t i s vi rus has a 
genome o f  6 . 8  x 1 0
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mo lecu l a r  we ight ( 5 9 )  and three 
pro te i n s  of 2 0 0 , SO, and 2 9  kd . The 50 kd prote in i s  
pho sphory lated and interna l to the vi rion enve lope 
( 6 , 2 0 , 2 1 ) . The gp 2 9  i s  the· tran smembrane prote in 
( 3 6 ) . The g lycopo lypep t i de o f  2 0 0  kd i s  the pep lome r 
( enve lope ) g lycoprote in ( 2 0 , 2 1 )  and carr i e s  anti gen i c  
determinant s re spon s ib le  f o r  t h e  induction o f  
neutra l i z ing anti body ( 1 6 , 2 1 , 3 6 ) . The gp 2 0 0  sur face 
pro j ect ion is a l so a s sumed to be the viru s  
anti recep tor , wh i ch b i n d s  t o  ce l l u l a r  receptor s i te s to 
i n i t i a te infection (2 1 , 3 6 ) . 
Can ine coronavi rus ( CCV) and TGE have simi lar  
po lypept ide structure s and a re . c l ose ly re lated 
an tigenc i a l ly (20 ) .  Can i ne coronav i rus  wa s i so l a ted 
from mi l i tary dog s wi th d i a rrhe a ( 5 ) .  The i so late , 
de s ignated I-71, caused severe ga s t roente r i t i s in 
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puppies , but d i d  not in fec t  p i g l e ts (5 , 1 0 ) . Acute 
ente r i t is and dehydration deve loped three to seven days 
a fter inocu lat i on o f  susceptib l e  puppies ( 5 , 3 1 ) . The 
intestina l lesions were s imi l a r  to lesions seen in p i gs 
inocu lated wi th TGE and we re cha racte r i zed by vi l l ous 
atrophy and fus ion o f  i ntestina l vi l l i throughout the 
sma l l  intestine , espec i a l ly in the i leum ( 3 1 ) . The 
intest ina l vi l l i regene rated wi thin seven to ten days 
a fter i n fection and most dogs recover ( 5 ) . 
Sero logica l ly ,  CCV is mo re p redominant among kenne l 
dogs ( 6 2 - 8 7  percent } than among househo ld dogs ( 2 2 
pe rcent ) and the disease has·a more seve re course in 
very young compared to o lde r puppi es ( 7 1 )  • Canine 
coronavi rus has four structura l prote ins . Three are 
g lycosy lated , parti a l ly externa l to the v i rion 
enve lope , and have mo lecu l a r  we i ghts o f  2 0 4 , 3 2 , and 2 2  
kd ( 2 0 ) . One spe c i es i s  the nuc leocapsid prote in wh i c h  
i s  inte rna l t o  t h e  vi r i on enve lope and i s  simi lar  to 
the nuc leocapsid prote i n  o f  the other coronaviruses 
( 2 0 } . Can ine coronavi rus may have two memb rane 
prote ins of 3 2  and 22 kd . Both o f  these prote ins a re 
g lycosy lated and simi l a r  to the t ransmembrane gp o f  
other  coronavi ruses ( 2 0 ) . The  g lycosy lated prote in o f  
2 0 4  kd is the enve lope g lycoprote in , wh i ch i s  simi l a r  
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to the 200 kd gp o f  TGE (20). P resumab ly the 204 kd gp 
o f  CCV induces neutra l i z ing ant i body , but the functi ons 
o f  the prote i ns o f  CCV h ave not been adequate ly 
desc ribed and requi re further study . 
Be fore the p i oneering success o f  ·Koh ler and 
Mi lste in (34) o f  immorta l i z ing ant i body sec reting 
ce l ls ,  use o f  an t iv i ra l anti s e ra was a lways l imi ted by 
the po lyspec i fi c i ty wi th regard to i ndividua l ant i gen i c  
structures o f  a g iven v i ra l prot e i n  (73). Producti on 
of monospec i fi c  ant ise ra aga inst individua l v i ra l  
prote ins , part i cu lar ly mi no r  v i ra l  structura l 
components , was d i f f i cu l t (73). The prob lems 
associ ated with the po ly spec i fi c i ty o f  antisera a re 
avoi ded by the use o f  mono c l ona l antibodi es . 
Monoc lona l ant ibod i es have de f ined spec i fi c i t i es towa rd 
sing le anti gen i c  determinants and provide po tent ia l ly 
use fu l too ls for the ana l ysis o f  distinct structura l 
domai ns o£ a prote in (73). Due to the extreme 
spec i f i ci ty o f  monoc lona l ant i bod i e s , i t  is possib l e  to 
use them to de f ine spec i f i c  reg ions ( ep i topes ) of a 
prote in ( 6 6 ) . Monoc lona l an t ibod i e s  repre sent a 
homogenou s antibody popu l a t i on and thus ach ieve the 
h i ghest degree o f  monospe c i f i c i ty possib le for 
immuno log i c a l  reagents (73). I t  is po s s ib le to 
19 
identify a protein as performing a particular function , 
once an antibody is available which is capable of 
inhibiting that function (73). Monoclonal antibodies 
have been used to analyze the biological activities of 
murine coronavirus (71), bovine coronavirus (17,68), 
and several other coronaviruses (36,44). 
The avian coronavirus ,  avian infectious 
bronchitis virus ( IBV ) , has a surface projection gp 8 
that is an oligomeric protein of two to three copies of 
each of two glycoproteins , Sl (9 0 kd) (11) and 82 (84 
kd) (12 ). The 82 gp serves to anchor 8 while the 81 gp 
may form the major part of the bulbous distal end of 
the surface projection 8 (12 ). Avian infectious 
bronchitis virus , treated with urea to remove the Sl 
gp , is unable to induce virus neutralizing and 
hemagglutinating antibody. The 81 portion of the gp 
without the 82 portion present was able to induce these 
antibodies. This indicated that the 81 gp contained 
the appropriate epitopes for viral neutralization and 
hemagglutination and suggested that the epitopes for 
neutralization and hemagglutination were the same 
(13). This has been confirmed using monoclonal 
antibodies , which neutralize and prevent 
hemagglutination by IBV (44). These results suggest 
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that the hemagg lutination and neutra liza tion epi tope s 
on the vira l  su rface projection s are either identica l 
or in c lo se proximi ty to each oth e r  such that ant ibody 
attach ing to one antigenic site s terica l ly a l te r the 
structure of  the other antigeni c  s i te (4 4 ). 
Like the other coronav i ru se s , mouse hepatiti s  
v i ru s  (MHV) ha s a pho sphory lated nuc leocaps id protein 
o f  approxima te ly 50 to 60 kd (14 ,62,63 , 65) , and a 
tran smemb rane prote in (gp 23) wh i ch has a pron a s e  or 
brome l ain re si s tant portion (63). The sur fa ce 
pro j ection protein of  180 kd may unde rgo l imi ted 
proteo lyt ic  c leavage yie lding g ly coprotein s h a l f  the 
mo lecu lar weight or 9 0  kd (63). The sur face pro j ection 
protein is es senti a l  for virus a t tachment to rec eptors  
on t he  p la sma membrane (27 ) . Six di f ferent epitopic 
group s were found to be pre sent on the sur face o f  the 
MHV when a pane l of monoc lona l antibodie s  we re s tudied . 
Some o f  the epi tope s we re re spon s i b le fo r 
neutra l i z ation of  MHV and othe r s  c au sed fu sion o f  ce l l  
memb rane s (70 ). 
The gp 20 0 o f  TGE is simi l a r  to the gp 18 0 of 
MHV and induce s neutra lizing antibodie s  (16,2 0 ,36). 
The surface proj ection i s a l so a s sumed to be i nvo lved 
with virus adsorption to the ce l l  (2 0 ,36). Monoc lona l 
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antibodi e s  whi ch neutra l i z e  TGE by binding to surface 
projection s o f  the viru s  recogn i z e  four major an tigen i c  
s i te s  o r  epi tope s ,  whi c h  wi l l  i nduce neutra l i z i ng 
antibodie s to thi s vi ru s , whi le six  ep itopic group s 
have been reported for MHV ( 20 , 70 ) . 
A monoc lona l antibody that neutra l i z ed BCV and 
inh ibi ted BCV hemagg lutinat ion of rat erythrocyte s 
immunoprec ip itated the gp 1 40 ,  or hemagg lutinin o f  BCV 
( 1 7 ) . In contra st to the s e  finding s , Vautherot et . a l .  
(68 ) reported two monoc l ona l antibodies  wh ich had 
neutra l i z at ion and hemagg lutinat ion activi t ie s , but 
immunoprec ipitated a g ly coprote i n  o f  105 kd ra ther than 
1 40 kd as repo rted by Deregt ( 1 7 ) . The re sults o f  
Vautherot et . a l . (68 ) are di f f i cu l t  t o  interpret s ince 
the gp 1 4 0 ha s been prev iou s ly reported to be the 
hemaggu ltinin o f  BCV ( 3 3 ) . Pre s en t ly , the sur face 
prote in of BCV re spon s ib le for induction o f  
neutra l i z ing and hemagg lut i n ing antibodie s  ha s not been 
identified. Monoc lona l antibodie s to BCV wou ld provide 
a too l for furth er de fin ing the bio logica l ly act ive 
region s  o f  the BCV prote in s and the ir  ro le in 
pathogene s i s  of di sea se . 
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MATERIAL S  AND METHODS 
Ce l l s. Human re c ta l tumor ( HRT- 1 8 ) ce l l s  we re 
obtained f rom Dr. G. N .  Woode ( Department of Veteri nary 
Mi crobio logy , Iowa State Uni ve r s i ty , Ame s , IA) , and 
ma inta ined on RPMI 1 6 4 0  me dium ( Gibco Labo ratori e s , 
Chagrin Fa l l s , OH ) a s  prev i ou s ly de s c ribed ( 6 7 ) .  A 
continuous l ine o f  swine t e s t i c le  ce l l s  ( 38 ) we re 
obta ined from the Nati ona l An ima l Di sea se Center , Ame s , 
IA , and propagated in Eag l e ' s  b a s a l medium (M. A .  
Bioproducts , Wa lkersvi l le ,  MD) supp l emented wi th 3 %  
(v /v ) lacta lbumin hydro ly s a te
-
. Crande l l  fe line k i dney 
(CRFK ) ce l l s  we re obtained f rom R. Crande l l  ( Vete rinary 
Medica l Di agno s t i c  Laboratory , Amari l lo ,  TX ) and 
mainta ined on Eag le' s  min imum e s sent i a l medium ( MEM) -
(Gibco Laboratorie s , Chag r i n  Fa l l s , OH ) . Al l med i a  
were a l so supp lemented wi th 2 0 0  �g /ml  streptomycin , 4 0 0  
U / m l  o f  peni c i l l i n , 1 �g /ml  fung i z one , and 10 % (v / v )  
i rradi ated fe ta l bovine s e rum ( FBS ) (Hyc lone , Logan , 
UT ) for growth media o r  5 %  ( v /v ) FBS fo r ma intenance 
med i a. Ce l l s  we re ma intained a t  3 7  C in a humidi f i e d  
atmo sphe re o f  5 %  co2. 
Mye loma ce l l  l ine s , P 3 -X6 3 -Ag 8 . 6 5 3  (ATCC , 
Rockv i l le ,  MD); NS-1 (D . Gab r i e l s on , No rth Dakota S t a te 
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Univers i ty , Fargo , ND ) J  and S P 2 /0M1 (Sa lsbury 
Laboratories , Char l es C i ty ,  IA)  were 
a z aguan i ne - resistant d e r iv i ti ves of non-sec re ting l ines 
o f  mye loma ce l l  c lones . These mye loma
-
ce l l  l ine s we re 
mainta ined on Du lbecco's mod i f i c a t ion of  Eag le's med i um 
( Du lbecco's MEM )  supp lemented wi�h 5 0 0  �g streptomyc in , 
1 , 0 0 0  U pen i c i l l in , 1 %  ( v/v ) So lution I ,  1 %  ( v/v ) 
non-essenti a l  amino ac i ds , and 1 0 %  ( v/v ) FBS . So lut i on 
I consisted o f  1 0 0  m l  o f  sa l ine o r  disti l led water 
containing 1 , 3 2 0  mg oxa loace t i c  a c i d , 80  mg insu l in , 
and 5 5 0  mg sodium pyruvate ( S i gma Chemi ca l Co . , St . 
Louis , MO ) . Mye loma ce l ls were i ncubated at  3 7  C in a 
humid i f i e d  a tmosphere o f  1 0 %  co2• 
Vi ruses . The Neb raska strain o f  bovine 
coronavi rus ( BCV) and hemagg lutinating 
encepha lomye l i tis vi rus ( HEV 6 7N )  we re obta ined from a 
comme r c i a l source (ATCC , Rockv i l le , MD). The Purdue 
stra in of transmissib le  gastroenteri t is vi rus ( TGE ) was 
supp l ied by Dr . E .  H .  Boh l , Oh i o  Agr i cu l tura l Research 
and Deve lopment Center , Wooster , OH . Can ine 
coronavi ru s  ( CCV I - 7 1 )  was obta ined from Dr . L. 
Carmic hae l ,  Corne l l  Un ive rsi ty , I thaca , NY. Bov ine 
coronavi rus was propagated on HRT- 1 8  ce l ls ,  HEV 67N1 
and TGE we re grown on ST  ce l ls ,  and CCV I - 7 1 wa s 
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propagated on CRFK ce l ls .  
Vi rus stocks were p repa red by propagation o f  
v i rus ma i nta ined on the app rop r i ate ce l l  line in 
se rum- free med i a .  When v i rus spe c i f i c  cytopa thi c  
e f fects were obse rved i n  8 0 %  o f  the ce l l  mono laye r, 
ce l ls we re sc raped from the f lask , fro z en , and thawed 3 
times . Ce l l  debris was removed by centri fugation a t  
1 , 2 4 0  x G .  The v i rus con t a i ni ng pe l lets we re 
resuspended in approx imate ly 1/ 2 0 0  the origina l vo lume , 
dispensed into sma l l  a l i quots , and stored at - 7 0  C .  
These vi rus stocks we re used i n  a l l  assays in th is 
study . 
Product i on o f  hyb r i doma ce l l  l ines . 
Eight-week-o ld Ba lb/c mi ce we re i nocu lated 
intrap eritonea l ly at 15 and e i ght days prior to fus i on 
wi th 0 . 5  m l  o f  BCV emu lsi f i ed with an equa l vo lume o f  
Freund ' s  comp lete adj uvan t . Mice were aga in inoc u l a ted 
intrape ritonea l ly wi th a suspens i on of BCV in sa l i ne at 
th ree , two , and one days p r i o r  to the harvest of s p l e en 
ce l ls for product i on o f  hyb r i domas . Mice we re a l s o  
inocu lated intravenous ly w i th a suspension o f  BCV i n  
sa l ine at two and one days p r i o r  t o  harve st o f  sp leen 
ce l ls .  
Sp leen ce lls from mi ce inocu lated wi th BCV 
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were fused with mye loma ce lls us ing a mod i f i cation of 
the procedure de scribed by Ga l fre e t . a l . ( 1 9 ) • 
. 7 . . Approx imate ly 1 0  sp leen ce l l s from hype rimmun1zed m1ce 
we re fu sed wi th 10 7 mye loma ce l l s ·us irig 5 0 %  
po lyethy lene g lyco l (M. W .  400 0 )  ( E .  Me rck , Darmstadt , 
Ge rmany ) .  Parenta l mye loma and sp l een ce l l s  were 
e l iminated by propaga ting the hybri doma ce l l s in media 
contain ing hypoxanth i ne , ami nopte rin , and thymi dine . 
Hybridoma s were di stributed i n to 2 4 -we l l  t i s sue cu lture 
p late s and incubated unt i l s i gn i f i cant growth wa s 
apparent within two to th ree we eks after fus ion . The 
cu l ture f luids from each we l l  o f  viab le hybridomas were 
te s ted for antibody produc t i on by an enzyme - l inked 
immuno sorbent a s say (EL I SA )  and indi rect 
immunof luore scence (IFA ) . Hybri doma s whic h reacted 
wi th BCV on the EL I SA or  IFA a s s ay were subc loned a t  
l e a s t  twice by l imi ting di lution in 9 6 -we l l  mi crot i ter 
p late s . Asc i t i c  f luids we re ob tained by 
6 7 
. 
intrape r i tonea l i n j ect i on o f  10 to 1 0  hybridoma cel l s  
into Ba lb/c mi ce primed two to three weeks previous ly 
wi th Pri stane- (2, 6, 10, 1 4 -tet rame thy lpentandec ane, Si gma 
Chemi ca l Co . , St . Loui s, MO) . Cu lture and a s c i t i c  
f luids  we re further screened for ant ibody reactiv i ty to 
the co ronavi ruse s used in th i s  s tudy by 
h emagg lutination inh i b i tion , f luorescent focus 
neutra l i z ation , vira l neutra l i z ation , and immune 
e l ectron mi c roscopy . 
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Enzyme - l inked irnrnunosorbent assay ( EL I SA)  for 
mono c lona l antibody to BCV . The ELI SA was per formed 
using a described technique ( 6 9 )  • . The EL I SA ant igens 
we re produced by free z i ng and thawi ng BCV ino cu l ated 
and un inocu lated HRT- 1 8  ce l ls three times fo l lowed by 
centri fugation to remove ce l l  deb ris . Irnmu lon I 
mi croti te r  p lates ( Dynatech Laborato ries , Inc . , 
Alexandri a ,  VA) we re coated wi th 1 0 0  � 1  per we l l  o f  a 
previous ly determined optima l.di lution o f  BCV stock and 
HRT- 1 8  host ce l l  ant i gen in a carbonate-bi carbonate 
coating bu f fer (pH 9. 6 ) .  The p l ates we re incubated 
four hours at 3 7  C and stored a t  4 C at least 
forty-eight hours be fore use . The coated p lates were 
then washed three times i n  PBS (pH 7 . 2 ) , conta ining 
0 . 0 5 %  Tween 2 0  ( S igma Chemi ca l Co . , St . Louis , MO ) , and 
0 . 2 % ( w/v ) ge latin ( S igma Chemi ca l Co . , St . Lou is , MO ) 
be fore use . 
One -hundred mi cro l i ters o f  a 1 : 5 d i lut i on o f  
hybrid cu l ture f lu i ds we re added t o  the BCV-coa ted 
p l ates and incuba ted for one hou r  at 3 7  C. P late s  we re 
then washed three times to remove the unbound ant ibody , 
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and bound antibody wa s dete cted by addition o f  1 00 � 1  
pe r we l l  o f  a 1 : 1 , 0 0 0  di lut i on o f  pe roxida se -con j ugated 
goat ant i -mou se IgG ( Cooper B i omedic a l , Ma lve rn , PA ) . 
A fte r incubati on at 3 7  C for one hour, the p lates were 
wa shed th ree time s  i n  PBS to remove the unbound 
conjuga te and 1 0 0  � 1  per wel l o f  sub strate (2 , 2 '  
az ino-di - ( 3 -e thy l ben z thi a z a l i ne -7-su l fon i c  ac i d, ABTS ) 
in  c i tr i c  acid bu f fer  ( pH 4 . 0 ) wa s added to each we l l .  
Contro l s  for the EL ISA te s t s i nc luded HAT media 
conta ining FBS ( contro l fo r ant ibody in FBS ) ,  rotavi ru s  
ce l l  cu lture f luids from a hybri doma producing antibody 
to a po rcine rotav i ru s  ( negative contro l )  , and 
po lyc lona l rabb i t  anti -BCV ant i serum (po s i t ive 
con tro l ) . Afte r twenty mi nu te s  o f  incubation at room 
tempe rature, the ab sorbance o f  each we l l  wa s recorded 
at dua l wave length s of 4 0 5/4 1 5  nm wi th a Ti te rtek 
Multi skan spectrophotome ter ( F low Labo rato r i e s, Inc . ,  
Rockvi l le, MD ) . 
Asc itic f luids  we re ti te red by ELI SA using 
ten - fo ld di lution s  o f  the monoc lona l ant ibody . Asciti c 
f luids w i th tite r s  lowe r than 1 : 1,0 00 we re ti trated 
us i ng doub l ing di lut i on s . The ti te r s  we re furthe r 
de f ined by di lut ing the a s c i ti c  f luids  in incremen t s  
between the highe st EL I SA po s i t i ve and nega tive 
di luti ons , i. e. asc i t i c  f lu i d  pos i t ive with an ELI SA 
t i te r  of  1 0
3
, but negat i ve at  1 0
4
, was di luted to 
1 0 , 0 0 0 , 2 0 , 0 0 0 , 3 0 , 0 0 0  • • •  9 0 , 0 0 0 , 1 0 0 , 0 0 0  to dete rmine 
the de fini tive ti ter. Opt i ca l density readings 
obta ined for the norma l host c e l l  ( HRT- 1 8 ) antige n  
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( background ) we re subtracted f rom the optic a l  dens i ty 
readings o f  the pos i t ive asc i t i c  f lui ds and the 
negative contro l samp les .  These data po int s were then 
graph ed wi th the di luti on o f  asc i t i c  f lu i d  on the 
x -axis and opt i ca l dens i ty on the y -axis . The best f i t  
l ine f o r  these data po ints was de termined and 
extrapo lated to de te rmine where the l ine f rom data 
points of the pos i t ive asc i t i c  f luid crossed the l ine 
from data po ints of the nega tive contro l. The EL I SA 
t i te r  o f  posi tive asc i t i c  f lu i ds was a rbi trari ly 
determined to be two d i luti ons prior to the point of 
crossover. 
Isotyping. The isotype o f  each monoc lona l 
an tibody was determi ned using a comme rci a l  
immunodi f fusion test ( Mi l e s Laborator i e s , Napervi l le ,  
I"L ) • 
Indirect immuno f luo rescence . Spot s l ide s we re 
prepa red with ce l l s in fected with e ach coronavi rus . 
Mono layers  o f  the appropri ate ce l l  type we re inocu l a ted 
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as described in the s e c t i on on v i ruses . When vi ra l 
spe c i f i c  cytopath i c  e f fe c t s  were ob served in 5 0 %  o f  the 
i no cu lated mono l aye r , a s te r i le bacte r i o l ogica l l oop 
was used to s crape ce l ls loose f rom the f la s k and 
t r ansfer the ce l l  suspens i on to we l l s  on the spot 
s l ides . The vi ru s - i n f e c ted ce l l  suspen s ion wa s a l lowed 
to a i r  dry and then fixed in acetone fo r ten minute s at 
room temperature . S l ide s we re stored in p l a s t i c  s l ide 
boxes at - 7 0 C unti l u sed . Two - fo ld ser i a l  di lution s 
o f  asc i t i c  f luids beg inn i ng at 1 : 1 0 we re added to 
dup l i c ate spot s  on the s l ides . The asc i t i c  f luids that 
h ad a strong pos i tive re a c t i on were t i te red aga in using 
two- fo ld se r i a l di lut i ons beginn i ng at a 1 : 1 0 0  
d i lution . The s l ide s were incuba ted for 3 0  minute s in 
a humidi f i ed c hambe r a t  3 7  C ,  washed in PBS , and a 1 : 3 0 
d i lut i on o f  a f luoresce i n - i sothi ocyanate conjugated 
rabbi t  anti -mouse IgG (Cappe l l  Laborator i es , We s t  
Che s te r , PA ) , was added . After a n  addi t i onal 3 0  minute 
i n cuba t ion at 3 7  C ,  s l ides we re wa shed in PBS, rin s ed 
i n  doub le-di s t i l led wa te r , and a cove rs l ip wa s app l ied 
wi th mounting media ( PB S -g lyce ro l , pH 9 . 0 ) (Di fco 
Laboratorie s ,  Detro i t , M I ) . S l ide s we re obse rved with 
a Ze i ss epi f luore s cent mi c ro s cope (Zei s s  I nve rto s cope , 
C a r l  Ze i s s , We s t  Ge rmany ) .  The i nd i rect 
immuno f luorescent t i te rs o f  e a ch tested asc i t i c  f lu i d  
was the h ighest di lut i on a t  whi c h  f luorescence cou ld 
sti l l  be observed .  
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Hemaggluti nation ( HA )  and hemagglut ination 
inhib i tion ( HAI } tests . These tests we re done in 
9 6 -we l l  " U-bottom "  mi c ro t i te r  p lates as previ ous ly 
descr ibed ( 2 3 ) . A l l  hyb ridomas we re screened fo r 
i nh i b i tion o f  hemagglut i n a t i o n  by BCV . The HA ti ter o f  
t h e  stock BCV was dete rmi ned by add i ng 5 0  � 1  o f  1 %  
washe d  r a t  eryth rocytes t o  5 0  � 1  o f  a se ri e s  o f  
two - fo ld di lutions o f  BCV . The vi rus and red b lood 
ce l ls we re incuba ted for one to two hours at amb i ent 
room tempe rature a nd the t i te r  was expressed as the 
reciproca l of the h ighest d i lut ion of BCV to cause 
comp lete agg lutinati on o f  the rat e rythrocytes . A 
d i lution o f  BCV equ iva lent to four HA units was added 
to two- fo ld di lut i ons of each monoc lona l ant ibody i n  
ste ri le  PBS . P lates were then i ncubated for · thi rty 
minutes at 3 7  C .  Rat e ry throcytes ( 1 % )  were then added 
to the vi rus-antibody mixture and i n cubated for one 
hour a t  room temperature. The t i te r  o f  each monoc l ona l 
ant ibody wa s recorded as the rec i proca l of  the highest 
di luti on capab le of inhib i ting hemagg lutination of fou r 
HA un i ts o f  BCV . 
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Vi ra l neutra l i z a t i on ( VN ) . Two - fo ld 
di lut i on s , starting at a 1 : 4 di lut i on o f  a s c i t i c  
f luids , were made in t h e  app rop r i ate media supp lemented 
wi th 5 %  ( v /v ) FBS . An e qua l vo l ume o f  medi a conta ining 
100 TC rn 50 o f  each coronav i ru s  te sted in thi s  study wa s 
added to each we l l  o f  a 9 6 -we l l  p 1 ate exc luding the 
ce l l  contro l .  Ce l l  contro l s  contained no virus  or 
a sc i t i c  f luid . Asc i ti c  f luids wh i ch produced ant ibody 
spe c i f i c  for rotav i ru s  we re u sed a s  negative contro l s . 
The po s i tive contro l wa s po lyc lona l rabb i t  
ant i -coronav i ru s  serum fo r BCV , HEV , TGE , or CCV . 
Fo l lowing a one hour incub a t ion a t  3 7  C ,  100 � 1  o f  the 
appropri ate ce l l s  were added to the vi ru s -antibody 
mixture . P l ate s we re incuba ted a t  3 7  C for three to 
four day s and each we l l  ob served for the pre sence or . 
ab sence o f  spec i f ic v i ra l cytopa thi c  e f fect . Titers 
we re exp re s sed a s  the rec i proc a l o f  the h ighe st 
di lut i on o f  ant ibody whe re no cytopath i c  e ffect wa s 
ob served . 
F luore scen t focu s neutra l i z ation a s say ( FFN ) . 
To determine the neutra l i z i ng ant ibody tite r  o f  each 
mono c lona l antibody , equa l vo lume s of two - fo ld seri a l 
di lut i on s  o f  the antibody and BCV we re mixed and 
a l lowed to re act at 37 c for one hour . The stock BCV 
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wa s used at a di luti on previou s ly determined to produce 
1 0 0  f luo res cent ce l l s pe r we l l . The antibody -v i ru s  
mixture wa s then added to 9 6 -we l l  p late s o f  wa she d 
HRT- 1 8  mono laye r s . Afte r a one hour incubati on at 3 7  
C ,  the i nocu lum wa s removed and 2 0 0  � 1  o f  se rum- f ree 
med i a  wa s added to each we l l . P l ate s we re then 
incubated at 3 7  C for 4 8  hour s . At the end of the 
incuba t ion pe riod , ce l l s on  the p l ate s we re fixed with 
6 0 % acetone and a 1 : 2 0 di lut i on o f  po lyc lona l rabbi t  
ant i -BCV serum wa s added t o  e a c h  we l l  and incuba ted at  
3 7  C for  30  minute s .  The exce s s  s erum wa s wa shed o f f  
and a f luore scein-i soth i o cyariate c on j ugated goat 
anti -rabb i t  IgG wa s added to each we l l .  P l ate s  we re 
i ncubated at 3 7  C for 3 0  minute s , wa shed in PBS , and 
1 0 0  � 1  of PBS wa s added to each we l l  be fore 
ob servation . P la te s we re ob s e rved with an 
ep i f luore s cent mic ro scope a s  previou s ly de scr ibed in  
the secti on on  indi rec t  immuno f luore scen ce . · The . 
neutra l i z ing antibody t i te r  wa s expre s sed a s  the 
rec iproca l of the h ighe s t  d i lut i on o f  serum that 
reduced f luore scence by 8 0 %  compa red to the virus  
contro l we l l s . 
Brome l a in treatment o f  BCV . Brome l a in 
dige s tion o f  the outer g ly coprote in pep lome r s  o f  BCV 
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wa s done a s  p revi ou s ly de s c r ibed ( 8 , 2 0 , 5 1 , 5 2 ) . One 
vo lume of a brome l a i n  s o lut i on con s i sting o f  1 . 3 mg / m l , 
0 . 0 0 1  M EDTA , and 0 . 0 5 M d i t h iothre i to l  ( S igma Chem i c a l 
Co . , S t . Loui s ,  MO ) wa s added to n ine vo lume s o f  BCV . 
The suspen s i on wa s i ncubated a t  3 7  C for two hour s and 
then centri fuged at 4 0 , 0 0 0  x g for 3 0  minute s . The 
supernatant wa s d i scarded and the vi rus  pe l let wa s 
re su spended in Hank ' s  ba lanced s a lt  so luti on for u s e  in 
i mmune e lectron mi cro scopy . 
Immune e lectron m i c ro s copy ( IEM) . A 
modi fi cation o f  the procedure o f  Sa i f  et a l  ( 5 6 )  wa s 
u sed . Equa l vo lume s o f  untreated or  brome l a in tre ated 
BCV and a s c i t i c  f lu i d s  from e ac h  c lone we re mixed and 
i ncubated at 37 C for one hour , then he ld ove rnight at 
4 C .  The suspen s i on wa s then centri fuged at 4 0 , 0 0 0  x g 
fo r 4 5  minute s to pe l le t  vi ru s -an tibody comp lexe s . The 
sup ernatant wa s d i scarded and the pe l let wa s 
re suspended in one drop o f  4 %  pho sphotung s t i c  acid 
( PTA ) pH 6 . 5 ,  two drops of  0 . 0 1 % bovine se rum a lbumin 
( BSA) fraction V ( S igma Chemi c a l Co . , St . Lou i s ,  MO ) , 
and doub le -di sti l led wa te r . The suspen s ion wa s sprayed 
with a g lobuonebu l i z e r  onto co l lodion and carbon co a ted 
gri d s  and examined on a H i tach i HU- 1 2A ( H i tachi Ltd . , 
Japan ) e lectron micro scope . Contro l s  inc luded 
unt reated and brome l a i n  t reated BCV mixed with e i ther 
negative a sc i t i c  f luid o r  po lyc lona l rabb i t  anti �BCV 
anti s erum a s  we l l  a s  b rome l a in t reated and untre ated 
BCV . 
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RESULTS 
S even hybri doma s f rom two s eparate fu s ions  
we re found to  secrete monoc l ona l antibodi e s  to  BCV , 
when sc reened by the EL I SA and I FA procedure s . The 
b i o log i ca l and antigen i c  spec i f i c i ti e s  of the seven BCV 
- hybridoma s are summa ri z ed i n  Tab l e  2 .  Monoc lona l 
antibod i e s  o f  the I gG
1 
i sotype we re mo st  common . 
Each o f  the seven hybr idoma s secreting 
monoc lona l antibody to BCV gave a po s i tive reac tion on 
the indi rect f luore scent antib ody t e s t  wi th BCV and 3./ 7  
( 4 3 % ) monoc lona l ant ibod i e s  a l so reacted wi th HEV � No 
memb rane f luore scence wa s ob s e rved . Cytopathic 
f luore scence va ried from a f ine granu lar f luore scence 
to di f fuse or g lobu l ar f luore s cence ( Fig . 1 ) . Immmuno­
f luore scent t i te r s  aga i n s t  BCV ranged from 1 : 1 0 to 
1 : 3 , 2 0 0 . The three hyb r i doma s ( 7 1- 4 4 , 6 - 1 , 6 - 4 ) wh i ch 
a l so reacted wi th HEV , had h i gher titers  to the 
homo logous ( BCV) compared to the hete ro logous ( HEV ) 
antigen . The IFA t i te r s  were f ive to 2 0  time s  highe r 
when BCV rather than HEV wa s u sed a s  antigen . 
Immuno f luore scent titers aga in st BCV ranged from 1 : 1 0 
to 1 : 3 , 2 0 0 .  The hybri doma s d i d  not produce ant ibody 
whi ch reacted on IFA aga i n s t  CCV and TGE in fected 
TABLE 2 .  Cha racte ri z a t i on o f  anti-BCV monoc lona l 
ant ibod i e s  
I FA t i ter 
2 
ELI SA t i ter 
3 
De s ignation I sotype BCV HEV BCV 
7 1 - 4 4  I gG
1 
1 : 1 , 6 0 0  1 : 8 0 1 : 1 5 0 , 0 0 0  
8 8 - 2 9  I gG2 a  
1 : 1 0 < 1 0 1 : 4 0 
2 5 - 4 8
1 I gG
1 
1 : 3 , 2 0 0  < 1 0 Negative 
4 - 2  I gG l 1 : 4 0 0  < 1 0 1 : 9 0 0 , 0 0 0  
4 - 7  I gG 1 
1 : 1 0 0  < 1 0 1 : 8 0 , 0 0 0  
6 - 1  I gG 1 . 
1 : 8 0 0  1 : 1 6 0  1 : 1 , 0 0 0 , 0 0 0  
6 - 4  I gGl 
1 :  8 0  0 . 1 : 1 6 0  1 : 9 0 0 , 00 0  
1 C lone 2 5 - 4 8  a l so neutra l i z ed BCV . 
2 
I FA = indi rect immuno f luore scence ; BCV = bov i�e 
coronav i rus ; HEV = hemagg lutinating encepha lomye l i t i s . 
No reaction wa s ob served by I FA when tran smi s s ib le 
ga stroente r i t i s vi ru s  and canine coronavirus  we re used 
a s  ant igens . The I FA t i te r s  we re expre s sed as  the 
rec iproca l of the h i ghe s t  d i l u t i on where f luore scence 
wa s s t i l l  ob served . 
3 EL I SA = en zyme - l inked irnmuno sorben t a s say .  
Tite r s  we re de termined a s  de ta i led in Ma te ri a l s  and 
Me thod s .  
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ce l l s .  
The ELI SA t i te r s  o f  the a sc i t i c  f lui d s  ranged 
from 1 : 4 0 to 1 : 1 , 0 0 0 , 0 0 0  as indi c ated by Tab le 2 and 
F ig s . 2 ,  3 ,  and 4 .  The t i te r  o f  each monoc lona l 
an tibody on the EL I SA wa s det e rmined by e st ima ting 
where the be s t  fit l i ne of the po s it ive data cro s sed 
the l ine from the data po i n t s  of the negative contro l .  
Two di lut ion s  prior to the l a s t  po s i tive di luti on wa s 
arb i tr a r i ly repo rted a s  the t i te r  o f  each antibody . 
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The ELI SA t i ters  for 4 - 2 , 4 - 7 , 6 - 1 , and 6 - 4  we re 2 , 2 5 0 ; 
8 0 ; 1 , 2 5 0 ; and 1 , 1 2 5  t ime s  greate r than the t i ters  on 
!FA , re spec tive ly . The EL I SA
.
t i te r  for 7 1 - 4 4 - wa s 1 0 0  
t ime s greater than the I FA t i te r  aga inst BCV and 8 8 - 2 9 
had an EL ISA t i te r  four- fo l d  greater than the !FA 
t i ter . Howeve r ,  2 5 - 4 8 , wh i ch had the h i ghe s t  ! FA 
t i ter , did  not react w i th BCV antigen on EL ISA.  
The bio logi ca l a ct ivi t i e s  of monoc lona l 
ant ibodi e s  were a l so a s sayed by HAI and v i ra l  
neutra l i z at i on . On ly l / 7  ( 1 4 % ) o f  the c lone s ( c lone 
4 - 7 ) inhib i ted hemagg lutinat i on of BCV at a low t i ter 
of 1 : 1 6 .  In the conventiona l v i ra l neutra l i z a tion 
te st ing , doub l i ng di lut ion s of the a s c i t i c  f luid wa s 
a l lowed to rea ct with 1 0 0  TC i o5 0 o f  BCV , HEV , TGE , and 
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Fig . 2 .  The ELISA titers o f  asc i t i c  f luids 2 5 - 4 8  (A) , 8 8 - 2 9  (0) , and negat ive 
contro l (e) . The opti ca l den s i ty ( S-N ) is expre s sed as the opt i c a l den sity o f  
the reaction between ascitic  f luid and BCV ( S )  and the opt i ca l den si ty o f  the 
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Fig . 3 .  The ELISA t i te r s  o f  a sc i t i c  f luids 7 1 - 4 4 (A) , 4 - 7 (0) , and nega t ive 
contro l (e) . The opt i ca l den s i ty ( S-N ) is expre s sed as the opt i c a l den s i ty o f  
the reaction between a sc i t i c  f luid and BCV ( S )  and the opt i ca l den s i ty o f  the 
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Fig . 4 .  The ELI SA tite r s  of a scitic  f luids 6 - 4  (A) , 4 - 2 (0) , 6 - 1  �) , and 
negative contro l (e) . The opt ica l den s i ty ( S -N ) i s  expre s sed as the opt i ca l 
den sity of  the reac tion between . a sc i t i c  f lui d and BCV ( S )  and the opt i ca l 
den sity of the reac tion between as ci tic f luid . and the norma l host ce l l  ( N ) . � 
tv 
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o f  the four v i ruse s .  However , i t  wa s ob served tha t the 
cytopathi c  e f fect ( CP E )  o f  BCV on HRT- 1 8  ce l l s wa s 
o ften di f f i cu lt to ob serve . S ince th i s  inf luenced the 
vi ra l neutra l i z ation a s say , an a lternative 
neutra l i z ation a s say , a f luo re s cent focus 
neutra l i z ation a s say ( FFN ) wh i ch doe s not re ly on CPE , 
wa s done . Two - fo ld d i lut i on s  o f  each mono c lona l 
antibody wa s mixed wi th a con stant di lution o f  BCV and 
the re su l t s  revea l ed that c lone 2 5 - 4 8  neutra l i z ed 8 0 %  
o f  the vira l infectivi ty o f  BCV at  a tite r  ranging f rom 
1 : 3 2 to 1 : 1 , 0 2 4 . No othe r c lone s showed neutra l i z ing . 
act ivi ty by FFN . 
Indirect immune e lectron microscopy wa s 
per fo rmed wi th each o f  the a s c i t i c  f luids and brome l a i n  
treated and untreated BCV . Di re c t  e lectron micro scopy 
o f  unt reated BCV reve a led a typ i c a l . BCV wi th a doub le 
fringe o f  sur face pro j e c t i ons  as  indi cated in Fig . S a . 
When BCV wa s trea ted wi th b rome l a i n , mo s t  o f  the outer 
row of sur face pro j ect i on s  were removed , but the inne r 
row o f  pro j ection s appeared to rema in intact ( F ig . Sb ) . 
When brome l a in trea ted BCV wa s incubated wi th a 
negat ive a sc i te s contro l ,  the inner row o f  sur face 
proj ec tion s  and a few rema ining sur face proj ect i on s  of 
the outer row we re e a s i ly ob served indi cating that no  
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F igure 5 .  ( a )  Norma l BCV mo rpho logy with two rows o f  
sur face pro j ec t i on s a s  indi cted b y  arrows ( Ba r  = 5 0  
nm ) ; ( b ) Treatment o f  BCV
.
with brome l a in re su l t s  in 
lo s s  of the outer row of surface pro j e c t i on s ( Ba r  = 5 0  
nm ) . 
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antigen-ant ibody reaction took p lace . As a po s i t ive 
contro l ,  BCV wa s incubated wi th po lyc lona l rabb i t  
anti -BCV s e rum ( F ig . 6 a ) . Thi s re su l ted i n  aggrega tion 
o f  virus  parti c l e s , 2 0  to 3 0  v i ra l pa rti c le s  we re 
ob served per aggregate , and the vira l morpho logy wa s 
ob scured by antibody bound to the sur face o f  the v i r a l 
pa rti c l e .  When brome l a i n  t re ated BCV wa s incubated 
wi th po lyc lona l rabb i t  an ti -BCV se rum , the re appeared 
to be more antibody a ttached to the treated virus  
parti c l e s  compa red to  the untreated viru s  ( Fig . 6b ) . 
The morpho log i c  detai l o f  the sur face pro j ections  on · 
the brome lain treated BCV compared to untre ated BCV 
parti c le s  wa s more di f f i cu l t  to obs e rve due to the 
increa sed amount of ant ibody , bound to the treated 
vi ru s . Al though more ant i body bound to treated BCV 
compared to untre ated BCV , incre a sed aggregat ion o f  
part i c le s o r  an incre a se i n  the numbe r o f  virus  
parti c le s  in the vi ru s -antibody agg regate s wa s not 
ob s e rve d . The sur face pro j ections  o f  BCV were 
parti a l ly ob scured when untreated BCV wa s incubated 
wi th a s c i t i c  f lu i d  2 5 - 4 8  wh i ch neutra l i z ed BCV on the 
FFN a s say ( F ig . 7 a ) . When brome l a in treated BCV wa s 
incubated with a s c i t i c  f luid from 2 5 - 4 8 , the reaction 
o f  the monoc lona l ant ibody and BCV wa s s imi lar to that 
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Figure 6 .  ( a )  Untreated BCV incubated wi th po lyc lona l 
rabb i t  anti -BCV anti serum ( po s i tive contro l )  s hows the 
BCV part i c l e s  aggregated in l a rge c lump s w i th surface 
pro j ections ob s cured a s  indi cated by arrow ( Ba r  = 
5 0  nm ) ; ( b ) Brome l a in treated BCV incubated with 
po lyc lona l rabb i t  ant i -BCV ant i serum show s  l a rge r 
amount s o f  antibody bound to the t reated compared to 
un t re a ted BCV i n  F i g . 6 a . Pep lomer s  ob scured by 
an tibody a re indi cated by arrow ( Ba r = 5 0  nm ) . 
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de sc r ibed fo r the react i on between the brome l a i n  
treated BCV and po lyc lona l rabb i t  anti -BCV se rum
· 
( Fi g . 
7 b ) . The re wa s increa sed b inding o f  antibody ob served 
when BCV wa s reacted w i th e i ther 2 5 - 4 8  or po lyc lona l 
rabb i t  anti -BCV se rum for b rorne l a i n  treated BCV. 
Antibody surrounded BCV pa rti c l e s  and sur face 
p ro j ect ion s  we re indi s ti ngu i shab l e  from antibody . 
As c i t i c  f luid from hyb r i doma s 7 1 - 4 4 , 8 8 - 2 9 , 4 - 2 , 4 - 7 , 
6 - 1 , and 6 - 4  did not b i nd to the sur face o f  BCV . The 
hybridoma s were not te s ted wi th HEV , TGE , and CCV by 
I EM s ince no neutra l i z a tion wa s obta ined in the v i r a l · 
neutra l i z a t ion a s say s . 
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F igure 7 .  ( a )  Untreated BCV incubated wi th a s c i ti c  
f lu i d  2 5 � 4 8 shows monoc lona l an tibody bound t o  the 
sur face pro j ections of the aggregated parti c le s  a s  
indi cated b y  a rrow ( Bar  5 0  nm ) ; ( b ) Brome l a in treated 
BCV i ncubated wi th the neutra l i z ing monoc l ona l 
ant ibody 2 4 - 4 8  s hows marked ly gre a te r amoun t s  o f  
antibody bound to the surface ( a s indi cated b y  arrow ) 
when compared to untreated BCV incub ated wi th a s c i t i c  
f lui d  2 5 - 4 8 .  T h e  sur face proj e ct ion s a r e  gre a t l y  
ob scured by monoc l ona l ant ibody a n d  a l a rge r amoun t o f  
antibody i s  bound t o  t h e  aggrega ted vi ru s  p a rt i c l e s  
{ B a r = 5 0  nm ) . 
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D I SCUS S I ON 
The ob j ective o f  the pre s ent s tudy wa s to 
deve lop and character i z e  a pane l o f  monoc l ona l 
antibodi e s  to the Nebra ska s train o f  bovine 
co ronavirus . Monoc lona l ant ibodie s  can be used to 
a s s oc i a te vira l po lypept i de s  with bio l og i ca l functions 
such a s  vi ra l attachment , neutra l i z ation , 
hemagg lutination , and ce l l  fu s i on . Monoc l ona l 
antibod i e s  have been used to c h a racte r i z e  the 
structura l po lypept ide s o f  avi an ( I BV) ( 4 4 ) , porcine 
( TGE )  ( 1 6 , 3 6 )  , murine ( MHV) ( 1 4 , 7 0 )  , and bovine ( BCV)  
( 1 7 , 6 8 )  co ronavi ru se s . The re a re on ly two report s in 
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the l i te ra ture de scr ibing the u se o f  monoc lona l 
ant ibodi e s  to de te rmine the the b i o logica l funct ion s o f  
the f ive to seven struc tura l po l ypepti de s  o f  BCV 
( 1 7 , 6 8 ) . Current evidence sugge s t s  the 
hemagg lutinating and neutra l i z a t i on ep i tope s on the 
sur face o f  BCV may e i th e r  be s imi l a r  ( 1 7 , 6 8 ) , or 
d i f fe rent ( 6 8 ) . Deve lopment o f  monoc l ona l antibodie s 
to the hemagg lutinin or neutra l i z a tion epi tope s o f  BCV 
wou ld be important not on ly in i dent i f ication o f  
structura l proteins o f  the vi ru s , but a l so cou ld be 
used in hemagg lu tination inh ib i t i on or neutra l i z ation 
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te s t s  for detection o f  antigen i n  c linica l mate r i a l or 
to dete rmine the degree of antigen i c  variation among 
di f ferent i so late s  o f  BCV . A l though BCV i s  pre sumed to 
be a s ing le se rotype , two mono c lona l antibod i e s  
di rected t o  the French s train o f  BCV fai led to 
cro s s -react with e i th e r  the Uni ted State s or Briti sh  
i so l ate s o f  BCV ( 6 8 ) . In  the pre sent study , seven 
monoc lona l antibodi e s  to bovine coronavi ru s  were 
characte ri z ed by bio logi ca l a s say s to dete rmine the i r  
reactivi ty wi th bovine c o ronav i ru s , transmi s s ib le 
ga stroenteriti s viru s , h emagg lutinating 
encepha lomye l i t i s  vi ru s , and canine coronavirus . O f  
the seven monoc lona l ant ibodi e s  c haracte ri z e d , 6 / 7  
reacted on the ELISA a s s ay , on ly the neutra l i z ing 
mono c l ona l antibody ( 2 5 - 4 8 ) c ou l d  not be detected u s �ng 
the EL I SA .  Al l monoc lona l antibod i e s  reacted with BCV 
on IFA and 3 / 7  a l so cro s s -rea c te d  wi th HEV . One 
monoc lona L antibody ( 4 - 7 ) inhib i ted vira l 
hemagg lutination , but d i d  not neut ra l i z e BCV , 
sugge s ting that the hemagg lutinin and neutra l i z a tion 
epi tope s are e i ther on d i f ferent g lycoprote ins or 
di f fe rent locations on the s ame g lycoprotein . The 
latte r hypothe s i s  wa s con f i rmed by immune e lectron 
mi cro scopy , since monoc l ona l ant ibody from c lone 2 5 - 4 8  
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neutra l i z ed and reac ted wi th brome lain  treated BCV . 
The enzyme - l i nked immuno sorbent a s say wa s used 
a s  the screen ing a s say to determine i f_ hybri doma s 
secreted ant ibody spe c i f i c  to BCV . The EL I SA i s  a 
high ly sen s i tive a s say ( 5 4 , 7 3 )  that i s  independent o f  
monoc lona l anti body i so type , and su itab le for rap i d  
a s s e s sment o f  the spec i fi c i ty o f  t h e  hybridoma 
antibodies ( 7 3 ) . Thi s a s say i s  dependen t on the 
abi l i ty of prote ins (ant ibod i e s  or vira l  protein s )  to 
adhere to a so l i d  pha se, wh i ch i s  usua l ly a p l a s t i c  
micro t i ter p late ( 5 3 ) . The binding o f  proteins  to the 
p l a s t i c  is pH and tempera ture dependent ( 5 3 )  • In the 
EL I SA used in th i s  study, BCV wa s bound to p l astic  
mi croti ter p late s . Cu l ture supernatant from 7 / 7  c l one s 
and a s c i t i c  f lui d from 6 / 7  c lone s reacted wi th BCV 
bound to the mi croti ter p la te s . On ly asc i t ic f luid 
from c lone 2 5 - 48 , wh ich neutra l i z ed BCV , did not react 
on ELI SA .  Th i s  re su l t  wa s not expected becau se cu l ture 
supe rnatant taken from hybri doma cu lture 2 5 - 4 8  prior to 
c loning did react on the ELI SA .  The lack of reac t iv i ty 
o f  a sc i t i c  f luid 2 5 - 48 on the ELI SA cou ld be exp lained 
i f : 1) the monoc lona l ant ibody degraded upon binding 
to BCV , adhe red to the so l i d  pha se, 2 )  the avi d i ty 
(b inding a f f i n i ty )  o f  the monoc lona l ant ibody to BCV 
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wa s weak and wa shing may h ave removed ant ibody bound to 
BCV , and 3 )  the . v i ra l epitope s recogn i zed by the 
monoc lona l ant ibody we re modi f ied , .  deg.raded , or ma sked 
when BCV wa s bound to the s o l i d  pha se . Monoc lona l 
antibodies  wh ich neutr a l i z e  porcine rotavi rus have a l so 
been reported to react  poor ly or  not at  a l l  on ELI SA 
(Ben fi e ld , pe rsona l commun i c a tion ) .  The ELISA te st  wa s 
the mo st sen s i t ive s e ro l og i c a l a s say fo r dete rmin i ng 
ant ibody because t i te r s  we re gene ra l ly 8 0  to 2 , 2 5 0  
time s higher than tite r s  ob ta ined wi th the IFA .  The 
higher ant ibody t i te r s  ob tained wi th the EL ISA comp a red 
to IFA con f i rms . previous report s that the EL I SA is  the 
mo st sen s i tive method to detect mo st monoc lona l 
ant ibodi e s  spec i f ic to BCV ( 6 8 ) . The monoc lona l 
ant ibodies  th at react w i th BCV i n  the ELI SA te st cou ld 
be used to deve lop an a n t i gen capture ELI SA to detec t 
BCV in feca l mate r i a l o f  i n f ected ca lve s . 
A l though the IFA i s  not a s  sen si tive an a s s ay 
a s  the EL I SA, a sc i t i c  f luid de rived f rom the si x 
nonneutra l i z ing and the one neutra l izing hybri doma s did 
react wi th ant igen i n  BCV in fected HRT- 1 8  ce l l s . The 
finding that 3/ 7  monoc l ona l antibodi e s  (7 1 - 4 4, 6 - 1, and 
6 - 4 )  a l so rea cted wi th ant igen in HEV infected ce l l s  
con f i rms previous repo r t s  that BCV and HEV share common 
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ant i gen s ( 6 , 7 1 ) . There a re a l so prote i n s  common to BCV 
whi ch are not pre sent in HEV s ince 4 / 7  nonneutra l i z ing 
monoc lona l antibod i e s  reacted on ly with BCV infected 
ce l l s .  Bovine co ronav i ru s  and HEV a re i n  the same 
antigen i c  grouping , whe rea s TGE and CCV a re in a 
di f fe rent ant igen i c  group ing o f  coronavi ru s ( 6 , 7 1 ) . 
Thus , we did  not expec t  any o f  the monoc lona l 
ant ibodie s to react wi th TGE or  CCV and thi s expec ted 
re su l t wa s ob served . 
A lthough BCV and HEV h ave be en repo rted to be 
antigen i ca l ly s imi l a r , mo s t  of the se studie s  were done 
u si ng po lyc lona l heterotypi c  s e rum and the re wa s 
con s i de rab l e  amb igui ty in re su lt s . The wi de spread 
occurrence of BCV-neutra l i z ing antibodie s in " norma l "  
human and an ima l se ra ( 2 2 , 5 7 )  inhib i t s  the use o f  suGh 
ant i sera in studie s of anti gen i c  inte rre lationship s . 
The anti -BCV antibod i e s  pre s en t  i n  human or anima l sera 
cou ld re su lt  from a p a s t  i n f e c t i on wi th BCV or a 
re lated co ronavi ru s . The u s e  o f  monoc lona l antibodi e s , 
wh ich a re homogenou s and monospec i fi c , avoids the 
prob l ems of cro s s-reacting antibod i e s  pre sent in 
po lyc lona l anti sera . Thu s , our data repre sent s the 
f i r s t  repo rt that monoc lona l antibod i e s  re cogn i z e  a 
common epi tope pre sent on BCV and HEV . The se three 
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monoc lona l ant ibodi e s  probab ly react with an interna l 
virion protein , nuc leocap s i d , o r  tran smemb rane 
prote ins , s ince the se monoc l ona l antibodi e s  did not 
p revent hemagg lutination or neutra l i z ation and we re not 
ob served by e lectron mi cros copy to b i nd to the vi rion 
surface . Previous repor t s  indic a te that the antigen ic 
s i te s  re spon sib le for induc tion of neutra l i z ing 
antibodie s  are a s soci ated wi th the sur face 
g lycoprote ins ( 7 1 )  and the v i rion hemagg lutin in o f  BCV 
i s  gp 1 4 0 , an exte rna l prot e i n  ( 3 3 ) . 
Coronavi rus  g ly copro te i n s  a re pre sent on the 
sur face of the vi ru s  and fun c t i on in inhibi t ion o t 
hemagg lutination ( 1 3 , 3 2 )  neutra l i z ation ( 1 3 , 1 4 ) , ce l l  
a ttachment ( 1 6 , 2 7 , 3 6 ) , and ce l l  fus i on ( 1 4 ) . In  th i s  
s tudy , c lone ( 2 5 - 4 8 ) neut ra l i z ed BCV and one other 
c lone ( 4 - 7  prevented hemagg lut inat ion of rat red b lood 
ce l l s  by BCV . The monoc l ona l antibod i e s  derived in 
thi s s tudy . were spec i f i c  to BCV , s i nc e  the other 
coronavi ruse s that we re te sted in the same or di f ferent 
antigenic group ing s we re not neutra l i z ed .  The 
de rivation of monoc lona l antibodi e s  wh i ch recogni z e  
separate epi tope s , one whi ch re su l t s  i n  vi ra l 
neutra l i z ation and one wh i ch prevent s hemagg lutination , 
wou ld sugge st that the vi ra l g lycoproteins containing 
the neutra l i z ation s i te and the hemagg lutinin are 
separate g lycoprote i n s . A l ternative ly , the two 
monoc lona l antibod i e s  may recogn i z e  sepa rate epi tope s 
on the same g lycop rotein and thi s g lycoprotein may be 
the s i te of both neutra l i z a ti on and the vira l 
h emagg lutinin . 
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Previou s  report s  have demon strated that BCV ha s 
four surface g lycoprote in s o f  1 4 0 , 1 2 0 , 1 0 0 , and 2 6  kd 
mo l ecu l a r  we ight ( 3 2 ) . Brome l a in dige stion o f  BCV 
remove s  a l l  g lycoprote i n s , except gp 1 4 0 , wh ich i s  the 
vi ra l hemagg lutinin ( 3 3 ) . The gp 1 4 0  is the inner row 
o f  sur face proj ection s  ob s e rved on e lectron micros copy 
in thi s s tudy and by othe r s  ( 3 2 ) . Brome l a in dige s t ion 
of BCV re su l ted in enhanced b inding of the neutra l i z ing 
monoc lona l antibody 2 5 - 4 8  to the vi rion . Thi s sugges t s  
tha t 2 5 - 4 8  binds t o  t h e  g p  1 4 0 ; wh i ch i s  reported t o  b e  
the on ly g lycoprote in re s i stant t o  brome lain treatment . 
Since brome lain treatmen t  enhan c ed antibody bindin g  to 
BCV , the epitope recogn i z ed by 2 5 - 4 8  may be pa rtia l ly 
ma sked by other surface g ly coprote in s wh i ch are removed 
by brome l a i n  trea tment . No p reviou s  studi e s  us ing 
monoc l ona l antibod i e s  to BCV and immune e lectron 
mi cro s copy techn ique s have been reported , but it ha s 
been de termined that brome l a i n  treatment o f  BCV wi l l  
a l so markedly enhance vi r a l hemagg lutination (3 3 ) . 
Wh i le our ob servati on s  th a t  monoc lona l antibody 2 5 - 4 8  
binds to epi tope s on the gp 1 4 0  i s  c i�cumstanti a l , the 
re su l t s  of the immune e le c t ron mi croscopy studi e s  and 
b rome lain dige stion o f  BCV suppo rt the previous 
ob servat ion s  of  King et . a l .  ( 3 3 )  that the gp 1 4 0  i s  
re s i stant to brome lain d i ge s ti on and i s  pre sent on the 
inn e r  row of  sur face proj e c t i on s  of the v i r ion . 
Howeve r ,  di rect  subs tan t i a t i on o f  the hypothe si s that 
monoc lona l an tibody 2 5 - 4 8 b i nds to the gp 1 4 0  wi l l  
require We stern b lotting and immunoprecipitation 
techn i que s .  
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Al though We ste rn b lott i ng and 
immunoprec ipitation we re not done in thi s study, 
monoc lona l an tibodi es , wh i ch both neutra l ize and 
inhibit hemagg lutinati on by BCV have been reported to 
precipi tate a gp 1 2 0  ( 1 7 ) , wh i ch is ana logous to the gp 
1 4 0  (hemagg lutinin ) de sc r ibed by King et . a l . ( 3 3 ) . 
Thi s sugges ts , as  do our re su l t s, that the s i te o f  
neutra l iza tion and hemagg lut ina t i on co-exi st on th e 
same g lycoprotein . In addi t i on, De regt et . a l .  ( 1 7 )  
repo rted that one neutra l izing monoc lona l ant ibody, 
wh ich did not hemagg lutinate, a l so pre c i pi tated gp 1 2 0 , 
further substanti ating the po s s ibi l i ty that there are 
separate neutra l i z at ion and h emagg lutination epi tope s 
on the gp 1 2 0 - 1 4 0  hemagg lutinin . 
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Monoc lona l antibodi e s  wh i ch neutra l i z e  the 
avi an co ronav i rus  I BV a l so preven t hemagg lutina t i on 
indicating that epi tope s fo r both funct ion s  a re loca ted 
on the same g lycoprotein ( 1 2 ) . However ,  IBV doe s not 
h ave a gp 1 2 0 - 1 4 0  dimer common to BCV and i t  is  
po s s ib le tha t  the neutra l i z a t i on and h emagg luti nat ion 
s i te s  on IBV may be sepa rate epi topes on the same 
g lycoprote in . Th i s  latter a l te rnative wa s sugge sted by 
Mockett et . a l . ( 4 4 ) . S ince the neutra l i z ation and 
hemagg luti nation s i te s  are �n c l o s e  prox imi ty to one 
another , neut ra l i z ing anti body a tta ching to one s i te 
may sterica l ly h inde r  the b ind ing o f  red b lood ce l l s to 
the hemagg luti nin . 
The re su lts  o f  th i s  and previous studies  
( 1 7 , 3 3 )  d i sagreed with Vauthe ro t  et . a l .  ( 6 8 ) , who 
repo rted tha t  epi tope s fo r both neutra l i zation and 
hemagg lutina tion re s i ded on gp l O S , wh i ch is ana logous 
to the gp 1 2 0  de scr ibed by K i ng et . a l .  ( 3 2 ) . The gp 
1 0 5  or 1 2 0  a re pre sent on the oute r row o f  sur face 
p ro j ection s  and can be remove d by b rome l a i n  dige stion . 
A l l o f  the monoc lona l antibod i e s  wh i ch neutra l i z ed o r  
inh ibited hemagg lutinati on, de s c r ibed by Vauthe rot et . 
a l . ( 6 8 ) a l so immunop re c ip i t a ted gp 1 0 5 . Howeve r ,  i t  
wou l d  b e  intere s t i ng t o  de t e rm i n e  i f  t h e  monoc lona l 
ant ibod i e s  de s c r i be d  by Vau the r o t  e t . a l .  ( 6 8 )  a c tua l ly 
b i n d  to b rome l a i n  t r e a t e d  v i ru s , wh i c h  wou ld be devo i d  
o f  g p  1 0 5 . Un fortun a t e l y , ou r monoc lona l antibody , 
wh i c h  p reven ted hemagg l u t i n a t i on ( 4 - 7 ) d i d  not b i nd to 
BCV on immune e l e c t ron mi c ro s copy. S i nce the 
hemagg lut i na t ion i n h i b i t i o n  t i t e r  o f  the a s c i t i c  f lu i d  
wa s l ow ( 1 : 1 6 ) , th i s  a n t i bo dy may h ave a l ow b i nding 
a f f i n i ty for the hemagg lut i n i n .  The re fore , the mi nute 
amoun t of antibody bound cou ld not be vi sua l i z e d  by 
e le c t ron mi c ro s copy . S i n c e  t h i s  antibody i nh i b i te d  
hemagg l u t i n a t i on , i t  i s  a s sumed t h a t  i t  recogn i z e s  an 
ep i tope on gp 1 4 0  or t h a t  t h e  ou t e r  l ay e r  o f  su r f a c e  
p ro j e c t ion s may have s t e r i c a l ly inte r fe r red wi th t h e  
b i nd i n g . 
In conc l u s i on , s even mono c l ona l an t i bod i e s  we re 
c h a r a c te r i z ed to de t e rm i n e  spec i f i c i ty for epi tope s on 
the Neb ra ska s t ra in of BCV . On l y  c lone 2 5 - 4 8  
neutra l i z ed BCV. No oth e r  c lone s n eu t ra l i z ed BCV , HEV , 
TGE , o r  CCV . Re su l t s  o f  t h i s -s tudy u s ing a 
n e u t r a l i z ing monoc lona l a n t ibody support previou s 
repo r t s t h a t  the neutra l i z a t i on a n d  hemagg luti n a t i on 
fun c t i on o f  the v i ru s  re s i de on the same g ly cop rote i n  
6 1  
6 2  
( 1 3 , 1 7 ) . Re su l t s  from the I EM s tudy u s ing the 
neutra l i z ing monoc lona l antibody and brome l a in treated 
vi ru s  provi de evidence to sub s tantiate the previous 
repo rt ( 1 7 )  that gp 1 4 0 , wh i ch i s  the vi ra l 
hemagg lutin in , i s  a l so the s ite o f  neutra l i z ation . 
( 
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